Filing Flows › Coya Therapeutics (COYA) › Q2 2026 › vs Q1 2026
Coya Therapeutics (COYA) Q2 2026 vs Q1 2026 (quarter over quarter)
Coya Therapeutics's revenue fell $7K (-3%) from $251K in Q1 2026 to $244K in Q2 2026.
Coya Therapeutics, Q2 2026: revenue $244K (+49% year over year), net loss $6.6M, operating cash flow −$7.4M. The chart draws each line against Q1 2026, the increases inside each band.
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $244K | $251K | −$7K | -3% |
| Other income, net | $409K | $433K | −$24K | -6% |
| Net loss | $6.6M | $7.2M | −$569K | -8% |
| Costs & expenses | $7.3M | $7.9M | −$601K | -8% |
| Operating costs | $7.3M | $7.9M | −$601K | -8% |
| Research & development | $5.0M | $4.1M | $934K | +23% |
| General & admin | $2.3M | $3.8M | −$1.5M | -40% |
| Operating cash sources | $8.3M | $8.4M | −$84K | -1% |
| Depreciation | $3K | $3K | $0 | 0% |
| Share-based compensation | $944K | $2.2M | −$1.3M | -57% |
| Cash used in operations | $7.4M | $6.2M | $1.2M | +19% |
| Net loss absorbed | $6.6M | $7.2M | −$569K | -8% |
| Working capital & other | $1.7M | $1.2M | $485K | +40% |
Questions
How much did Coya Therapeutics's revenue grow quarter over quarter in Q2 2026?
Coya Therapeutics's revenue fell $7K (-3%) from $251K in Q1 2026 to $244K in Q2 2026.